CancerNetwork: Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma
June 23, 2025
Andrew J. Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at UT Health San Antonio, was featured in this video. Watch Now …